Advertisement

Clinical picture. Neonatal signs and symptoms

  • M. Hayde
  • A. Pollak
Conference paper

Abstract

Postnatal infection with the protozoan Toxoplasma gondii is clinically asymptomatic in up to 90 percent of cases[1]. Since the pathogenicity of the parasite for the immunocompetent individual is limited, the course of infection with Toxoplasma gondii is subclinical in most cases, despite the generalized character of the infection with subsequent parasitemia of the host.

Keywords

Subclinical Infection Congenital Toxoplasmosis Prenatal Treatment Toxoplasma Infection Fetal Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Remington JS, McLeod R, Desmonts G (1995) Toxoplasmosis. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. 4th edn, Philadelphia, WB Saunders, pp 140–267Google Scholar
  2. 2.
    Thalhammer O (1983) Toxoplasmose und Schwangerschaft. Prophylaxe, Früherkennung und Therapie. Zbl Gynäkol 105:1086–1092Google Scholar
  3. 3.
    Gratzl R, Hayde M, Kohlhauser Ch, Hermon M, Burda G, Strobl W, Pollak A (1998) Follow-up of Infants with Congenital Toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbiol Inf Dis 17:853–858CrossRefGoogle Scholar
  4. 4.
    Hayde M, Pollak A, Gratzl R, Hermon M, Trittenwein G, Häusler M, Arzt W, Bernaschek G (1996) Die Bedeutung der Nachsorge von Kindern mit pränataler Toxoplasma-Infektion. Mitt Oesterr Ges Tropenmed Parasitol 18:125–130Google Scholar
  5. 5.
    Wolf A, Cowen D, Paige BH (1939) Toxoplasmic encephalomyelitis. A case of granulomatous encephalomyelitis due to a protozoan. Am J Pathol 15:657–694Google Scholar
  6. 6.
    Desmonts G, Couvreur J (1979) Congenital toxoplasmosis: a prospective study of 542 women who acquired toxoplasmosis during pregnancy. In: Thalhammer O, Baumgarten K, Pollak A (eds), Pathophysiology of congenital disease, Perinatal Medicine 6`h European Congress, Georg Thieme, Stuttgart, pp. 51–60Google Scholar
  7. 7.
    Koppe JG, Kloostermann GJ, Roever-Bonnet H, Eckert-Stroink JA, Loewer-Sieger DH, Bruijne JI (1974) Toxoplasmosis and pregnancy, with a long-term follow up of the children. Eur J Obstet Gynaecol Reprod Biol 4:101–110CrossRefGoogle Scholar
  8. 8.
    Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequeleae in children born with subclinical congenital toxoplasma infection. Pediatrics 66:767–774PubMedGoogle Scholar
  9. 9.
    Thalhammer O (1967) Pränatale Erkrankungen des Menschen. Georg Thieme Verlag, Stuttgart, pp 121–157Google Scholar
  10. 10.
    Thalhammer O (1966) Die angeborene Toxoplasmose. In: Kirchhoff H, Kräubig H (eds). Toxoplasmose. Georg Thieme, Stuttgart, pp. 161-173Google Scholar
  11. 11.
    Raue W (1975) Die Klinik der konnatalen Toxoplasmose. In: Wildführ G, Wildführ W (eds). Toxoplasmose. VWB Gustav Fischer Verlag, Jena, pp. 135–150Google Scholar
  12. 12.
    Desmonts G, Couvreur J (1974) Toxoplasmosis. In: Conn RB (ed) Current diagnosis 7. WB Saunders Company, Philadelphia, pp. 274–297Google Scholar
  13. 13.
    Feldman HA (1958) Toxoplasmosis. Pediatrics 22:559–574PubMedGoogle Scholar
  14. 14.
    Eichenwald HA (1960) A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae and therapy. In: Slim JC (ed) Human Toxoplasmosis. Munksgaard, Copenhagen, pp 41–49Google Scholar
  15. 15.
    Couvreur J, Desmonts G (1962) Congenital and maternal toxoplasmosis. Dev Med Child Neurol 4:519–530PubMedCrossRefGoogle Scholar
  16. 16.
    Alford CA, Stagno S, Reynolds DW (1974) Congenital toxoplasmosis: clinical, laboratory and therapeutical considerations, with special reference to subclinical disease. Bull NY Acad Med 50:160–181Google Scholar
  17. 17.
    Chatterton JMW (1992) Pregnancy. In: HoYen D, Alex WL Joss (eds) Human Toxoplasmosis, Medical Publications, Oxford, New York, Tokyo, pp.144–183Google Scholar
  18. 18.
    McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, Remington J, Meier P, Johnson D, Heydeman P, Holfels E, Withers S, Mack D, Brown C, Patton D, McLeod R (1994) Early and Longitudinal Evaluations of Treated Infants and Children and Untreated Historical Patients with Congenital Toxoplasmosis: The Chicago Collaborative Treatment Trial. Clin Inf Dis 18:38–72CrossRefGoogle Scholar
  19. 19.
    Guerina NG, Hsu HW, Meissner CH, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, Grady GF (1994) Neonatal serologic screening and early treatment for Congenital Toxoplasma gondii infection. N Engl J Med 330:1858–1863PubMedCrossRefGoogle Scholar
  20. 20.
    Couvreur J, Demonts G, Tournier G, et al (1984) Étude d’une série homogène de 210 cases de toxoplasmose congénitale chez des nourissons ages de 0 a 11 mois et dépistes de facon prospective. Annales de Pediatrie 31:815-819PubMedGoogle Scholar
  21. 21.
    Hohlfeld P, Daffos F, Thulliez Ph, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F (1989) Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatrics 115:765–769CrossRefGoogle Scholar
  22. 22.
    Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez Ph, Aufrant C, Valenti D, Cox WL (1988) Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318:271–275PubMedCrossRefGoogle Scholar
  23. 23.
    Roizen N, Swisher CN, Stein MA, Hopkins J, Boyer KM, Holfels E, Mets MB, Stein L, Patel D, Meier P, Withers S, Remington J, Mack D, Heydemann PT, Patton D, McLeod R (1995) Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1:11–20Google Scholar
  24. 24.
    Koppe JG, Loewer-Sieger DH, Roever-Bonnet H (1986) Results of 20-Year Follow-up of Congenital Toxoplasmosis. Lancet 1:254–255PubMedCrossRefGoogle Scholar
  25. 25.
    Couvreur J, Thulliez Ph, Daffos F, Aufrant Ch, Bompard Y, Gesquière A, Desmonts G (1993) In utero Treatment of Toxoplasmic Fetopathy with the Combination Pyrimethamine-Sulfadiazine. Fetal Diagn Ther 8:45–50PubMedCrossRefGoogle Scholar
  26. 26.
    Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, Trenque T, Schmit G, Quereux C, Guenounou M, Pluot M, Bonhomme A, Pinon JM (1998) Pyrimethamine-sulfadoxine Treatment of Congenital Toxoplasmosis: Follow-up of 78 cases between 1980 and 1997. Scand J Infect Dis 30:295–300PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2000

Authors and Affiliations

  • M. Hayde
  • A. Pollak

There are no affiliations available

Personalised recommendations